 |
Parkinsons News: 273 headlines |
|
|||||
Celebrity Fight Night Video  |
||||||||
|
||||||||
|
||||||||
| Sources used by our Parkinsons News Channel Research Team: | ||||||||
| The New York Times, CNN, FOX, CBS, BBC, Mayo Clinic, Johns Hopkins Medicine, UCLA Medical Center, National Institute of Health, Stanford Hospital, Memorial Sloan- Kettering, Yale Cancer Center, Massachusetts General Hospital, Brigham and Women's Hospital, University of Michigan, M. D. Anderson Cancer Center, National Institute of Health, American Cancer Association, NBC, Reuters News, American College of Cardiology, Journal of the American Medical Association & 100's more | ||||||||
| Links | ||||||||
| Barrow Neurological Institute | ||||||||
| Archives |
Thursday
US approves first skin patch to treat depression
READ MORE: "Selegiline, a monoamine oxidase inhibitor (MAO inhibitor), was first approved by the FDA in 1989 in capsule form for treatment of Parkinson's disease.
Doctors also prescribe selegiline to treat depressed patients who do not respond to the more commonly used antidepressants, such as Prozac, Zoloft and Paxil."
Doctors also prescribe selegiline to treat depressed patients who do not respond to the more commonly used antidepressants, such as Prozac, Zoloft and Paxil."